Literature DB >> 33187820

Corrigendum to "Inhibiting fibroblast growth factor receptors in cancer - the next generation": Annals of Oncology (2020) volume 31, 1285-1286.

M Schuler1.   

Abstract

Entities:  

Year:  2020        PMID： 33187820     DOI： 10.1016/j.annonc.2020.10.593

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

Review 1.  Capmatinib: First Approval.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2020-07       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.